Report Says Australia's PBS Reached 20-Year Low In Adding New Drugs
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaceutical Benefits Scheme has added the lowest number of new drugs to its subsidy list in 20 years, depriving patients of possible savings amounting to nearly $18 billion, according to a report.